Owner Illumina, Inc. a Delaware corporation

Convention US 28 May 2009 77/747038

Service Davies Collison Cave

Various Convention priority claimed: 28 May 2009, United States of America, No. 77/747038 in respect of "CLINICAL DIAGNOSTIC INSTRUMENTS, NAMELY NUCLEIC ACID SEQUENCERS, IMAGING DEVICES AND ANALYZERS; APPARATUS FOR SAMPLE PREPARATION, AMPLIFICATION, MIXING, HYBRI

Filing Date 3 June 2009

Class 5 Clinical diagnostic reagents, reagent kits, and beads with attached biomolecules, comprised primarily of enzymes, oligonucleotides and other nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, for clinical diagnostic purposes

Class 10 Clinical diagnostic instruments, including nucleic acid sequencers, imaging devices and analyzers; apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, including, arrays, beads and bead sets and flow cells; automated laboratory apparatus and systems, namely sample loaders and bar code readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for clinical diagnostic purposes

Class 42 Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals